Education
About Us
Working with TipRanks
Follow Us
Lexston Life Sciences Corp. (TSE:LEXT)
:LEXT
RESEARCH TOOLSreports
LEXT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.09 - C$1.06
Previous CloseN/A
Volume1.00M
Average Volume (3M)11.26K
Market Cap
C$1.07M
Enterprise ValueC$1.10M
Total Cash (Recent Filing)C$63.58K
Total Debt (Recent Filing)C$60.00K
Price to Earnings (P/E)―
Beta1.40
Next Earnings
Sep 22, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding7,362,600
10 Day Avg. Volume2,400
30 Day Avg. Volume11,257
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lexston Life Sciences Corp. News
LEXT FAQ
What was Lexston Life Sciences Corp.’s price range in the past 12 months?
Lexston Life Sciences Corp. lowest stock price was C$0.09 and its highest was C$1.05 in the past 12 months.
What is Lexston Life Sciences Corp.’s market cap?
Lexston Life Sciences Corp.’s market cap is C$1.07M.
When is Lexston Life Sciences Corp.’s upcoming earnings report date?
Lexston Life Sciences Corp.’s upcoming earnings report date is Sep 22, 2025 which is in 24 days.
How were Lexston Life Sciences Corp.’s earnings last quarter?
Lexston Life Sciences Corp. released its earnings results on Apr 04, 2025. The company reported -C$0.052 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.052.
Is Lexston Life Sciences Corp. overvalued?
According to Wall Street analysts Lexston Life Sciences Corp.’s price is currently Overvalued.
Does Lexston Life Sciences Corp. pay dividends?
Lexston Life Sciences Corp. does not currently pay dividends.
What is Lexston Life Sciences Corp.’s EPS estimate?
Lexston Life Sciences Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lexston Life Sciences Corp. have?
Lexston Life Sciences Corp. has 7,362,600 shares outstanding.
What happened to Lexston Life Sciences Corp.’s price movement after its last earnings report?
Lexston Life Sciences Corp. reported an EPS of -C$0.052 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Lexston Life Sciences Corp.?
Currently, no hedge funds are holding shares in TSE:LEXT
Company Description
Lexston Life Sciences Corp.
Lexston Life Sciences Corp. (LEXT) is a biotechnology company focused on the development and commercialization of innovative life science solutions. The company's operations span various sectors including drug development, diagnostic testing, and biotechnology research. Lexston Life Sciences is committed to advancing scientific research and bringing new medical technologies to market, leveraging its expertise in genomics and molecular biology.
Technical Analysis
Ownership Overview
1.91% Insiders
―
Mutual Funds
0.09% Other Institutional Investors
98.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---